News

Media Coverage

  • Most People Would Take A Blood Test For Alzheimer’s, Study Says

    About 85% of primary care patients said they’d take a blood test that looks for the toxic proteins linked to Alzheimer’s, according to a report published April 15 in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. These patients said they were interested even though nearly 3 out of 4 (73%) said they expect…

  • What You Should Know About the Xanax Recall

    Dr. Sterling Elliott, clinical pharmacist at Northwestern Medicine and assistant professor of orthopaedics at Feinberg School of Medicine, joins Lisa Dent to discuss the recall of Xanax, the popular anxiety medication.

  • When the Room Spins: Researchers Learn More About Vertigo—and How to Treat It

    Of the many age-related problems that pose a risk to adults in midlife and beyond, so-called vestibular and balance disorders can be especially dangerous—and joy-depriving—because they increase the risk of falls and fractures and can lead people to restrict their own movement for fear of triggering another episode. According to research at Northwestern University, vertigo…

  • Heart Disease Is Preventable. So Why Does It Kill So Many of Us?

    Risk for most cardiovascular disease builds over years and often over decades. Yet we seem to be caught off guard when it happens; these heart events are often viewed as sudden or unexpected. What if we could, years or decades before, predict the likelihood that a cardiovascular event may happen? In fact, we can: the…

  • Historic Decline in U.S. Overdose Deaths Threatened by Changing Street Drug Supply

    As of October 2025, the most recent month where preliminary data is available from CDC, roughly 71,542 people had died in the U.S. over a 12-month period. That’s down dramatically from the 12-month peak of nearly 113,000 drug deaths recorded in August 2023. “This is unprecedented and historic, for the longest consecutive months of decline,”…

  • New Targeted Therapy Gives Hope to Pancreatic Cancer Patients and Families

    A new drug is offering hope and time for patients and their families and doubling the survival rate for one of the most deadly cancers. Dr Deva Mahalingam is a Northwestern Medicine Oncologist. “There’s no real screening tool for pancreatic cancer, and so when it starts causing symptoms, typically patients come in with weight loss,…

Events